We are investigating the Board of Directors and Officers of Imperva, Inc. (“Imperva” or the “Company”) (NasdaqGS: IMPV) for possible breaches of fiduciary duty relating to the sale of the company to Thoma Bravo, LLC. (“Thoma Bravo”). Under the terms of the proposed transaction, shareholders of Imperva will receive only $55.75 in cash for each share of Imperva that they own.